According to Celltrion/HSP information you furnished, there are eight FoB’s in the collaboration: Remicade, Herceptin, Rituxan, Enbrel, Erbitux, Synagis, Humira, and Avastin: see page 9 of https://dl.dropbox.com/u/72115812/celltrion_kdb_report_04JAN2012.pdf .